Bibliographic data
`
`Title:
`
`Eye gel for atropine sulfate
`
`Pub/Pat no:
`
`CN1456161A
`
`Pub/Issue Date:
`
`2003-11-19
`
`Inventor(s):
`
`Applicant(s):
`
`JIDONG LI |DONGMIN YAO jE GAO
`
`LIU JDONG[CN]
`
`Classification:
`
`AGIK9/00AL, AGIK31/46AL, AGIP27/02AI
`
`Application number:
`
`CN200211 7622: 2002-05-10
`
`Priority number:
`
`CN2002117622 2002-05-10;
`
`Abstract of CN1456161A
`
`An atropine sulfate gel for examining eyeground, enlarging pupil, and treating kerartitis and
`iridocyclitis is prépared from atropine sulfate, hydroxypropyl methylcellulose, bori¢ acid, borax
`and phenylmethylhydroxy amine -chicride. Its advantages are long stay time in eye, and high
`curative effect and biological utilization rate,
`
`
`
`Title:
`
`Eye gel for atropine sulfate
`
`Pub/Pat no:
`
`CN1456161A
`
`Pub/Issue Date:
`
`2003-11-19
`
`Inventor(s):
`
`Applicant(s):
`
`JIDONG LI |DONGMIN YAO jE GAO
`
`LIU JDONG[CN]
`
`Classification:
`
`AGIK9/00AL, AGIK31/46AL, AGIP27/02AI
`
`Application number:
`
`CN200211 7622: 2002-05-10
`
`Priority number:
`
`CN2002117622 2002-05-10;
`
`Abstract of CN1456161A
`
`An atropine sulfate gel for examining eyeground, enlarging pupil, and treating kerartitis and
`iridocyclitis is prépared from atropine sulfate, hydroxypropyl methylcellulose, bori¢ acid, borax
`and phenylmethylhydroxy amine -chicride. Its advantages are long stay time in eye, and high
`curative effect and biological utilization rate,
`
`
`
`[19] FEARSMRHRARFEMe
`
`A61K 9/00 A61P 27/02
`
`[12] AAAS Fl ig Fi AH
`[21] Figs 02117622.1
`
`.
`k
`
`ah
`
`
`[43] AAPA 2003 A 11 519
`
`[11] BARS CN 1456161 A
`
`[21] Hig= 02117622.1
`
`[22] BISA 2002.5.10
`[71] IBA ARAB
`
`thit
`110027 TAWA RAR RK =
`“5 ff 12 Hi 4 ‘SPA a AH 25 A BR
`EZ Fl
`[72] HAA XARA WRK OUR RIK
`
`
`ALA BORG 1 TL BEBE 3 BA
`A
`
`[54] BARR TiMB FG BR A eeee
`[57] i=
`
`AS Be We Be — Fb 25 Wa Aa SC oS—Far, BS BT FE —
`
`TAP
`TOR a] CBS FS aeBS FF,
`fa BT Gh AE ae FE FE BY BAL br
`—
`M — HIREHR, ASAT ZG i Ae HLi2
`Car
`M — AEsWahHEFT, BEARhSELULIEAE. SedNa
`
`
`SEcee
`PSPS, ACK HBCTL. A WAY CHS mR BATE A Hl
`PSRFREI, AMAIA le THRU LdCT city SEE
`
`PY fe Ba INTa) FS Pal el; EL Sy 2STToP
`cm
`ARMA FA RE,
`28 DT BR Za zee Pe. EEK
`Le
`AAZE: MARTein, FRA ASAE, DR, AD
`ae
`Wh, SAGAS FA ESieil) Fe it KE WI 7K A PEE FL
`ae]
`(Fa ZEER 2c 78ee TS RR, PEA,
`a
`ESAT ERR &AG AT A a, RAP OR ANT
`7
`Ali, AUS bs, t2 Ay PAA sae. WE
`
`TRAE ZEAEYAIT
`
`
`
`
`
`
`$e 7 F* AR HB ARAL BR
`
`
`
`ISSN1008-4274
`
`
`
`02117622. 1
`
`Mm
`
`FA)
`
`BE kK
`
`AL/La
`
`1. APRSReRROI, ERAPORR. Aebe. AA
`F FARR. WAREA SATIFERBEFA; A2A
`
`BGRFE MAARAEB:BA - CFE) ACB - 8 - SE - AAMAS, 2.
`
`1] -3-~ RRB — KAW: HICKRHA Atropine sulfate ophthalmic gel;
`
`WiEHE A Liusuan Atuopin Yanyongningjiao; MBPT RRA RRARB
`
`FE AATFA, AREF4SA BY A), AS a i24 7A RBFE
`
`FA REIBS . GitBalFE ih By SESEA)a)RRFPEea RRAB
`
`ROT: SPARARTIE RH 1.0% (w/w); SPA PARRA 4.0% (w/w);
`
`SHIRA 0.5% (w/w); SHWE A 1.0% Cw/w); SAARI 0.01% (w/w).
`
`BQAbTyBAYSAl PAEOE SeBS aK, BA. BULABA. RR
`
`MAR, HPA, BPR: DARA AIRE, PPR: Dm
`
`ARTFE 2SRY, FAKBEE, FERED; OE, PR, 4P
`
`32, BNE. Sb, MB TE WA BURTSF PEAERR. AEAOER
`
`Ra, RECSSEAS TERRE, RAVERRR. bis
`
`TEP, HDBRE: (DEA BEATEBERLEF CpH=5. 0-6. 0) DESTFA
`
`TREK,
`
`(2)-5 RNR. HRSARNAROAR CHEE 60-80°C) BARE
`
`BEM He, QAR AWASRESEP C45-55°C) Peet
`
`Wf.ENTIRE (115°C, 30 48H).
`
`2. RRABR 1 TAHARI, REEF RADARMOT
`
`Mb] FE daSRR RRA, ASESMRRIEPEARA
`
`FARRAReeAoAOSt ATAO, AREERORA, AS BkAGE, AAR
`
`RK. WRERAR STH: RRR RAR ARMA, REA
`
`0. 5-5. 0% Cw/w); EHRBLSFS EETERA 0-20. 0% (w/w); HERA 0-5. 0%
`
`Cw/w); OBR A 0-10. 0% (w/w); ARALAE AER Hy 0-0. 05% Cw/w).
`
`
`
`02117622. 1
`
`ie AA
`
`S81/30L
`
`vitPBZBAYFE vita BIA eeBS
`
`Pi RAR
`
`
`ABAWBFRROR—incPl$6ith——FS OASEBS, OF
`FIREFARRAR. AGRIAE. WHATARR. HURRERARSH
`
`IT
`
`BRA
`
`BAIRERRERR AIA. CEST, BRRHEITAASEA 1. OMERCOLA
`
`25H); FSHRAAAS PRREAD 1. OMEMES, RAED 1. OORTTEAR. Tt
`
`POP]FE oRRRRAAARLR, ZEBRA BTBLAME bolaAe
`
`RBSCAFRAD, HERR, BRR. RAPTFCAIRAD REBT B aIAAT
`
`FeAl AEBOFIE
`
`AeA A
`
`ATSRBABK, OMAWHEREAS, BCA —PPARREE,
`
`RRRae25, AMER T FERBOE. ERA BINTSa.
`
`ABD, RREADARKANEDAAE, ITMMARSt.
`
`RRWNRAARE: RBMMAWSHA PRATERWERIE
`
`PENI EA, MARAERRBA PRR, RRA. ARE
`
`BOF :
`
`BeBHT FE aA BEATeA, TFA: GRFC AERA BEE, Ae:
`
`- CGRFPZE) ACM — 8 — RAE - ARIAS. 2. 1] - 3 - SRR—KAD:
`
`4%: Atropine sulfate ophthalmic gel; WISH: Liusuan Atuopin yanyong
`
`ningjiao; RBMTMRARRARRMmHABT, RITA eSRB
`
`AAR, AintARPA RE. RiPFonAs +SR
`
`TtRAGE PICALRYRA: FP RRORTFEA 0. 1-5. 0%
`
`
`
`02117622. 1
`
`vi WB H2/3H
`
`(w/w); SISA PEAR 0-20. 0% (w/w); SHABRH 0-5. 0% (w/w); SD
`
`4 0-10. 0% (w/w); RULE ERRA 0-0.05% (w/w). AAAIFSPS EEESE
`
`RFA 400m] EAA, RK. Ae. RAH, RPS,
`
`il)CIE BARESRs DUAR, PE: DOARTEA
`
`Ais). FhKBAR, FESR: F220 Bie, ARK, Oe, BN.
`
`Ab, RASCSEA. REESERI. FECRRRSEIYOy
`
`RAR, BHPRARRRIRRRB. LRA, RORKE:
`
`(DFSA EAEEEREFE CpH=5.0-6.0) DENAKA, O50. HR
`
`eespeoheeae CHaREIE 60-80°C) LARUERMN, GMA
`
`PABAFGLBBURIGSYF (45-55°C) SEP, OPA (115°C,
`
`30 434).
`
`KANAB: RRAARRSARAPRA: C1). Bit
`
`POPULAERARREA FB Ab. BEFRAISER. AR CRE
`
`7PPEAREA.(2). AFRO, BRAMAAIC
`
`BT EGROLA. AUERAR LCRPAFEaBCRSE, ZEIRA
`
`NK, AAFERWRADRAL: ALLERAR, RRPFoR
`
`FREER, AE. DSRKH. PAE. AA, RRP
`
`RBARULE, BAAREA. APRITA, POA
`
`RAZANNA,APRSRMAi. (3). RTE
`
`APNEAUERBLA ZG4A)A, 30 SERBRATIRAE. il, FPR, RR
`
`RSEMLAAMINL, REA SBP9%bl. HH, RIBHAYER
`
`ARK. ARDSRI CHR) 4. FPR. PRBFE ARIA eRe
`
`RR, URESKEE BS AG.
`
`SiePl
`
`MbFi 1:
`
`PRPHEts
`
`Fo PRATER
`
`wae
`
`1.05%
`
`4.0 5%
`
`LO
`
`
`
`02117622. 1
`
`viBB B38 /3H
`
`WR
`
`AGAR PB RR
`
`EY FA Zk
`
`PRESEE:
`
`0.5 5%
`
`0.01 FE
`
`Hil A 100 SE
`
`@. BUbABFA PESERBE aK, EK.
`
`@. WALA BOM. RRMA, RPS. DA Hille RAREE,
`
`@. MARA RR, BPM:
`
`@. MARR, KBEB, FMA,
`
`©. Fi 220 Aiipiye, ARK, oe, BNA.
`
`MhTF 2:
`
`Wit BAT FE
`
`Fe BES ER
`
`Wig
`
`ime
`
`RACAS AR
`
`1 SY FA 7k
`
`BREA:
`
`0. 1-5. 0 FE
`
`0. 1-20.0 5%
`
`0. 1-5. 0%
`
`0. 1-2.5 #
`
`0. 01-0. 5 9%
`
`Hil 100 Fe
`
`©. RTRHRA PSRARES eK, WK.
`
`@. RABY. MRMAR, MHS, WARE,
`@. MARKER, RAEBH:
`
`®. MARBAICR, *teKESE, RORY,
`
`©.
`
`FA 220 Bihtiales, ARK, Se, BN.
`
`ARAM OIE, WtihK., SHABAERL, RRAHEE.
`
`Pel 1 Ay Bit RBS)$C ir ARFSAHhSR
`
`
`
`02117622. 1
`
`i Fs
`
`SB1/ 14
`
`
`
`SAL AR PBI
`
`LEREA
`
`
`
` RR.
`
`
Accessing this document will incur an additional charge of $.
After purchase, you can access this document again without charge.
Accept $ Charge
This document could not be displayed.
We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.
Your account does not support viewing this document.
You need a Paid Account to view this document. Click here to change your account type.
Your account does not support viewing this document.
Set your membership
status to view this document.
With a Docket Alarm membership, you'll
get a whole lot more, including:
- Up-to-date information for this case.
- Email alerts whenever there is an update.
- Full text search for other cases.
- Get email alerts whenever a new case matches your search.
One Moment Please
The filing “” is large (MB) and is being downloaded.
Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.
Your document is on its way!
If you do not receive the document in five minutes, contact support at support@docketalarm.com.
Sealed Document
We are unable to display this document, it may be under a court ordered seal.
If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.
Access Government Site
